Literature DB >> 12187450

Neuropsychological test performance of patients with Friedreich's ataxia.

Tone Wollmann1, Jose Barroso, Fernando Monton, Antonieta Nieto.   

Abstract

Although recognized as one of the most common hereditary diseases of the nervous system, the neuropsychological deficits in Friedreich's ataxia (FA) have rarely been studied. A protocol was constructed to assess the major cognitive areas in patients with FA and pair-matched normal controls. Motor difficulties, dysarthria and fatigability were taken into account. Neuropsychological assessment showed decreased motor and mental reaction times, reduced verbal span, deficits in letter fluency, impaired acquisition and consolidation of verbal information, proactive interference effect, and alterations in complex visuoperceptual and visuoconstructive abilities, in comparison with the control group. Magnetic resonance images showing cerebellar atrophy in the majority of patients suggest that cerebellar degeneration and the interruption of afferent and efferent cerebellar connections could be related to the cognitive deficits shown by our patients.

Entities:  

Mesh:

Year:  2002        PMID: 12187450     DOI: 10.1076/jcen.24.5.677.1014

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  17 in total

1.  Personality and Neuropsychological Profiles in Friedreich Ataxia.

Authors:  Sabrina Sayah; Jean-Yves Rotgé; Hélène Francisque; Marcela Gargiulo; Virginie Czernecki; Damian Justo; Khadija Lahlou-Laforet; Valérie Hahn; Massimo Pandolfo; Antoine Pelissolo; Philippe Fossati; Alexandra Durr
Journal:  Cerebellum       Date:  2018-04       Impact factor: 3.847

2.  Superior Visual Search and Crowding Abilities Are Not Characteristic of All Individuals on the Autism Spectrum.

Authors:  Ebony Lindor; Nicole Rinehart; Joanne Fielding
Journal:  J Autism Dev Disord       Date:  2018-10

3.  Utilisation of advance motor information is impaired in Friedreich ataxia.

Authors:  Louise A Corben; Martin B Delatycki; John L Bradshaw; Andrew J Churchyard; Nellie Georgiou-Karistianis
Journal:  Cerebellum       Date:  2011-12       Impact factor: 3.847

4.  Psychosis Complicating Friedreich Ataxia.

Authors:  Christos Ganos; Daniel Schöttle; Christine Zühlke; Alexander Münchau
Journal:  Mov Disord Clin Pract       Date:  2014-11-28

5.  Health-related quality of life and depressive symptoms in Friedreich ataxia.

Authors:  Javier Pérez-Flores; Atteneri Hernández-Torres; Fernando Montón; Antonieta Nieto
Journal:  Qual Life Res       Date:  2019-09-28       Impact factor: 4.147

6.  Ocular motor fixation deficits in Friedreich ataxia.

Authors:  Darren R Hocking; Joanne Fielding; Louise A Corben; Phillip D Cremer; Lynette Millist; Owen B White; Martin B Delatycki
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

7.  Measuring Inhibition and Cognitive Flexibility in Friedreich Ataxia.

Authors:  Louise A Corben; Felicity Klopper; Monique Stagnitti; Nellie Georgiou-Karistianis; John L Bradshaw; Gary Rance; Martin B Delatycki
Journal:  Cerebellum       Date:  2017-08       Impact factor: 3.847

8.  Impairment in motor reprogramming in Friedreich ataxia reflecting possible cerebellar dysfunction.

Authors:  Louise A Corben; Martin B Delatycki; John L Bradshaw; Malcolm K Horne; Michael C Fahey; Andrew J Churchyard; Nellie Georgiou-Karistianis
Journal:  J Neurol       Date:  2009-12-03       Impact factor: 4.849

9.  Friedreich ataxia: executive control is related to disease onset and GAA repeat length.

Authors:  Wolfgang Nachbauer; Thomas Bodner; Sylvia Boesch; Elfriede Karner; Andreas Eigentler; Lisa Neier; Thomas Benke; Margarete Delazer
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

10.  Fronto-cerebellar dysfunction and dysconnectivity underlying cognition in friedreich ataxia: The IMAGE-FRDA study.

Authors:  Ian H Harding; Louise A Corben; Elsdon Storey; Gary F Egan; Monique R Stagnitti; Govinda R Poudel; Martin B Delatycki; Nellie Georgiou-Karistianis
Journal:  Hum Brain Mapp       Date:  2015-10-27       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.